|
|
.
See Category: Neoplasms
See Header: Benign neoplasm of short bones of lower limb
ICD-10 (CM) Code and Descriptor
|
D16.32 |
Benign neoplasm of short bones of left lower limb
|
D1632 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 11 |
| 41.86%
|
27.44%
|
9.77%
|
11.16%
|
2.33%
|
1.86%
|
2.33%
|
0.93%
|
0.47%
|
0.47%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D16.32*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
41
|
56
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
39
|
1,600
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
33
|
123
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
33
|
64
|
|
J2405
|
ONDANSETRON HCL INJECTION |
26
|
102
|
|
73630
|
X-RAY EXAM OF FOOT |
23
|
23
|
|
J7120
|
RINGERS LACTATE INFUSION |
22
|
26
|
|
88311
|
DECALCIFY TISSUE |
21
|
21
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
20
|
106
|
|
28104
|
REMOVAL OF FOOT LESION |
17
|
17
|
|
28124
|
PARTIAL REMOVAL OF TOE |
17
|
17
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
17
|
18
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
14
|
47
|
|
J2001
|
LIDOCAINE INJECTION |
14
|
112
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
14
|
15
|
|
J1885
|
KETOROLAC TROMETHAMINE INJ |
13
|
23
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
12
|
16
|
|
28108
|
REMOVAL OF TOE LESIONS |
10
|
10
|
|
80048
|
METABOLIC PANEL TOTAL CA |
10
|
10
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
10
|
10
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D16.32 related to the following DRG Codes:
564-566
|
